经导管主动脉瓣置换术后心脏外科手术的回顾性分析
本研究回顾性分析41例TAVR术后接受心脏手术的患者,排除12例急诊术后并发症患者,纳入29例。二次手术中位时间23个月,主要适应证为人工瓣感染(15例)、瓣膜退变或功能障碍(7例)及疾病进展(7例)。再次主动脉瓣置换占82.8%,手术死亡率10.3%,1年总生存率83.0%,认为TAVR术后常规心脏手术可行且并发症率低。
要点
- TAVR术后二次心脏手术中位时间23个月,8例在术后1年内需手术。
- 主要适应证为人工瓣感染性心内膜炎(15例)和瓣膜退变或功能障碍(7例)。
- 手术死亡率10.3%,1年总生存率83.0%,无脑血管不良事件。
核心结论
- TAVR术后常规心脏手术可行,结果合理且并发症率低。
研究设计与样本
- 回顾性分析2012年12月至2020年2月单中心41例TAVR术后心脏手术患者,排除12例围术期并发症急诊手术,最终纳入29例。
主要发现
- 中位年龄76岁(68-80),男性占58.6%。
- 二次手术中位时间23个月(8-40),8例在TAVR术后第一年内需手术。
- 手术指征:人工瓣感染性心内膜炎15例,瓣膜退变或功能障碍7例,瓣膜、主动脉或冠状动脉疾病进展7例。
- 再次主动脉瓣置换24例(82.8%),未观察到主动脉根部或主动脉-二尖瓣连续性并发症。
- 手术死亡率10.3%,3例(10.3%)需体外生命支持中位3天(3-3天),术后无脑血管不良事件。
临床怎么用
- TAVR术后患者需长期随访,警惕人工瓣感染、退变及疾病进展,及时评估再次手术指征。
局限性
- 回顾性单中心小样本研究,排除急诊手术患者,结果可能不适用于TAVR围术期并发症需急诊手术者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objective of this study was to retrospectively analyse surgical outcomes of patients undergoing secondary cardiac surgery after initial transcatheter aortic valve replacement (TAVR). METHODS: Between December 2012 and February 2020, a total of 41 consecutive patients underwent cardiac surgery after a TAVR procedure at our institution. Patients who underwent emergency operations due to periprocedural complications such as ventricular rupture and TAVR dislocation were excluded from this study (n = 12). Thus, 29 patients were included in the analysis. Data are presented as medians (25th-75th quartiles) or as absolute numbers (percentages). RESULTS: The median age was 76 years (68-80); 58.6% were men. The median time to a secondary conventional procedure was 23 months (8-40), with 8 patients requiring surgical intervention within the first year post TAVR. The indications for secondary conventional procedures were prosthesis endocarditis (n = 15), prosthesis degeneration or dysfunction (n = 7) and progression of valvular, aortic or coronary artery disease (n = 7). Surgical redo aortic valve replacement was performed in 24 patients (82.8%). No complications involving the aortic root or the aortomitral continuity were observed. The operative mortality was 10.3%. Extracorporeal life support was required in 3 patients (10.3%) for a median duration of 3 days (3-3 days). No adverse cerebrovascular events were observed postoperatively. Postoperatively, 4 patients (13.8%) required a pacemaker and 7 patients (24.1%) required renal replacement therapy. Overall survival at 1 year was 83.0%. CONCLUSIONS: Conventional cardiac surgical procedures following TAVR are feasible with reasonable results and a low complication rate.
引用
- Saha S, Peterss S, Mueller C, et al. Cardiac surgery following transcatheter aortic valve replacement. Eur J Cardiothorac Surg. 2021. PMID: 34021322. doi:10.1093/ejcts/ezab217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。